nodes	percent_of_prediction	percent_of_DWPC	metapath
Drospirenone—NR3C2—hindbrain—brain cancer	0.028	0.063	CbGeAlD
Drospirenone—PGR—blood vessel—brain cancer	0.0273	0.0614	CbGeAlD
Drospirenone—Cerebral infarction—Carmustine—brain cancer	0.0269	0.101	CcSEcCtD
Drospirenone—PGR—hindbrain—brain cancer	0.026	0.0586	CbGeAlD
Drospirenone—Thrombosis—Procarbazine—brain cancer	0.0198	0.0744	CcSEcCtD
Drospirenone—NR3C2—brainstem—brain cancer	0.016	0.0361	CbGeAlD
Drospirenone—AR—Coregulation of Androgen receptor activity—KDM4C—brain cancer	0.0154	0.0553	CbGpPWpGaD
Drospirenone—PTGS2—endothelium—brain cancer	0.0148	0.0332	CbGeAlD
Drospirenone—NR3C2—telencephalon—brain cancer	0.0142	0.032	CbGeAlD
Drospirenone—PTGS2—Prostaglandin Synthesis and Regulation—S100A6—brain cancer	0.0139	0.05	CbGpPWpGaD
Drospirenone—PTGS2—blood vessel—brain cancer	0.0136	0.0307	CbGeAlD
Drospirenone—Embolism—Temozolomide—brain cancer	0.0132	0.0496	CcSEcCtD
Drospirenone—Thrombosis—Carmustine—brain cancer	0.0124	0.0465	CcSEcCtD
Drospirenone—NR3C2—pituitary gland—brain cancer	0.0116	0.0261	CbGeAlD
Drospirenone—NR3C2—medulla oblongata—brain cancer	0.0112	0.0252	CbGeAlD
Drospirenone—Haemoglobin—Lomustine—brain cancer	0.0112	0.0419	CcSEcCtD
Drospirenone—Haemorrhage—Lomustine—brain cancer	0.0111	0.0416	CcSEcCtD
Drospirenone—PGR—Nuclear signaling by ERBB4—GFAP—brain cancer	0.0108	0.0389	CbGpPWpGaD
Drospirenone—PGR—pituitary gland—brain cancer	0.0108	0.0243	CbGeAlD
Drospirenone—AR—telencephalon—brain cancer	0.0105	0.0237	CbGeAlD
Drospirenone—NR3C2—midbrain—brain cancer	0.0102	0.023	CbGeAlD
Drospirenone—NR3C2—spinal cord—brain cancer	0.00997	0.0225	CbGeAlD
Drospirenone—Breast pain—Temozolomide—brain cancer	0.00973	0.0365	CcSEcCtD
Drospirenone—BCHE—brainstem—brain cancer	0.00967	0.0218	CbGeAlD
Drospirenone—PTGS2—Prostaglandin Synthesis and Regulation—S100A10—brain cancer	0.00964	0.0347	CbGpPWpGaD
Drospirenone—NR3C2—Nuclear Receptor transcription pathway—ESR2—brain cancer	0.00906	0.0326	CbGpPWpGaD
Drospirenone—NR3C2—endocrine gland—brain cancer	0.00898	0.0202	CbGeAlD
Drospirenone—NR3C2—head—brain cancer	0.00887	0.02	CbGeAlD
Drospirenone—AR—gonad—brain cancer	0.0088	0.0198	CbGeAlD
Drospirenone—AR—pituitary gland—brain cancer	0.00858	0.0193	CbGeAlD
Drospirenone—BCHE—telencephalon—brain cancer	0.00858	0.0193	CbGeAlD
Drospirenone—PGR—endocrine gland—brain cancer	0.00835	0.0188	CbGeAlD
Drospirenone—PGR—head—brain cancer	0.00824	0.0185	CbGeAlD
Drospirenone—NR3C2—central nervous system—brain cancer	0.00809	0.0182	CbGeAlD
Drospirenone—PGR—Ovarian Infertility Genes—ESR2—brain cancer	0.00801	0.0288	CbGpPWpGaD
Drospirenone—NR3C2—cerebellum—brain cancer	0.00791	0.0178	CbGeAlD
Drospirenone—PGR—central nervous system—brain cancer	0.00752	0.0169	CbGeAlD
Drospirenone—AR—spinal cord—brain cancer	0.00739	0.0166	CbGeAlD
Drospirenone—PGR—cerebellum—brain cancer	0.00735	0.0165	CbGeAlD
Drospirenone—Breast disorder—Hydroxyurea—brain cancer	0.00713	0.0267	CcSEcCtD
Drospirenone—Haemoglobin—Procarbazine—brain cancer	0.00708	0.0266	CcSEcCtD
Drospirenone—Haemorrhage—Procarbazine—brain cancer	0.00705	0.0264	CcSEcCtD
Drospirenone—BCHE—pituitary gland—brain cancer	0.00698	0.0157	CbGeAlD
Drospirenone—PGR—Nuclear Receptors—ESR2—brain cancer	0.00698	0.0251	CbGpPWpGaD
Drospirenone—BCHE—medulla oblongata—brain cancer	0.00674	0.0152	CbGeAlD
Drospirenone—AR—Notch-mediated HES/HEY network—HEY1—brain cancer	0.00672	0.0242	CbGpPWpGaD
Drospirenone—AR—endocrine gland—brain cancer	0.00665	0.015	CbGeAlD
Drospirenone—PTGS2—telencephalon—brain cancer	0.00661	0.0149	CbGeAlD
Drospirenone—AR—head—brain cancer	0.00657	0.0148	CbGeAlD
Drospirenone—NR3C2—brain—brain cancer	0.00642	0.0145	CbGeAlD
Drospirenone—BCHE—midbrain—brain cancer	0.00616	0.0139	CbGeAlD
Drospirenone—Affect lability—Temozolomide—brain cancer	0.00606	0.0227	CcSEcCtD
Drospirenone—BCHE—spinal cord—brain cancer	0.00601	0.0135	CbGeAlD
Drospirenone—AR—central nervous system—brain cancer	0.00599	0.0135	CbGeAlD
Drospirenone—PGR—brain—brain cancer	0.00597	0.0134	CbGeAlD
Drospirenone—AR—FOXA1 transcription factor network—SHH—brain cancer	0.00591	0.0213	CbGpPWpGaD
Drospirenone—Mood swings—Temozolomide—brain cancer	0.00584	0.0219	CcSEcCtD
Drospirenone—BCHE—Irinotecan Pathway—APC—brain cancer	0.00566	0.0204	CbGpPWpGaD
Drospirenone—Breast disorder—Temozolomide—brain cancer	0.00557	0.0209	CcSEcCtD
Drospirenone—PGR—Nuclear Receptor transcription pathway—ESR2—brain cancer	0.00552	0.0198	CbGpPWpGaD
Drospirenone—Haemoglobin—Hydroxyurea—brain cancer	0.00548	0.0206	CcSEcCtD
Drospirenone—Haemorrhage—Hydroxyurea—brain cancer	0.00545	0.0205	CcSEcCtD
Drospirenone—BCHE—endocrine gland—brain cancer	0.00541	0.0122	CbGeAlD
Drospirenone—PTGS2—pituitary gland—brain cancer	0.00538	0.0121	CbGeAlD
Drospirenone—BCHE—head—brain cancer	0.00534	0.012	CbGeAlD
Drospirenone—AR—Nuclear Receptors—ESR2—brain cancer	0.00532	0.0191	CbGpPWpGaD
Drospirenone—PTGS2—Arachidonic acid metabolism—CYP2C9—brain cancer	0.00531	0.0191	CbGpPWpGaD
Drospirenone—Medroxyprogesterone Acetate—CYP2C9—brain cancer	0.00523	0.471	CrCbGaD
Drospirenone—PTGS2—medulla oblongata—brain cancer	0.00519	0.0117	CbGeAlD
Drospirenone—Angiopathy—Hydroxyurea—brain cancer	0.00495	0.0186	CcSEcCtD
Drospirenone—Depression—Carmustine—brain cancer	0.0049	0.0184	CcSEcCtD
Drospirenone—PGR—Ovarian Infertility Genes—CDK4—brain cancer	0.00488	0.0175	CbGpPWpGaD
Drospirenone—BCHE—central nervous system—brain cancer	0.00488	0.011	CbGeAlD
Drospirenone—BCHE—cerebellum—brain cancer	0.00477	0.0107	CbGeAlD
Drospirenone—AR—brain—brain cancer	0.00476	0.0107	CbGeAlD
Drospirenone—PTGS2—midbrain—brain cancer	0.00475	0.0107	CbGeAlD
Drospirenone—Depression—Temozolomide—brain cancer	0.00473	0.0178	CcSEcCtD
Drospirenone—Nausea—Lomustine—brain cancer	0.00468	0.0176	CcSEcCtD
Drospirenone—PTGS2—spinal cord—brain cancer	0.00463	0.0104	CbGeAlD
Drospirenone—PGR—Validated nuclear estrogen receptor alpha network—ESR2—brain cancer	0.0046	0.0165	CbGpPWpGaD
Drospirenone—Haemoglobin—Carmustine—brain cancer	0.00443	0.0166	CcSEcCtD
Drospirenone—Haemorrhage—Carmustine—brain cancer	0.00441	0.0165	CcSEcCtD
Drospirenone—Haemoglobin—Temozolomide—brain cancer	0.00428	0.0161	CcSEcCtD
Drospirenone—Haemorrhage—Temozolomide—brain cancer	0.00426	0.016	CcSEcCtD
Drospirenone—AR—Nuclear Receptor transcription pathway—ESR2—brain cancer	0.0042	0.0151	CbGpPWpGaD
Drospirenone—PTGS2—endocrine gland—brain cancer	0.00417	0.00938	CbGeAlD
Drospirenone—PTGS2—head—brain cancer	0.00412	0.00926	CbGeAlD
Drospirenone—AR—SIDS Susceptibility Pathways—HES5—brain cancer	0.00404	0.0145	CbGpPWpGaD
Drospirenone—Erythema multiforme—Temozolomide—brain cancer	0.00403	0.0151	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.00401	0.0151	CcSEcCtD
Drospirenone—BCHE—brain—brain cancer	0.00387	0.00871	CbGeAlD
Drospirenone—Angiopathy—Temozolomide—brain cancer	0.00387	0.0145	CcSEcCtD
Drospirenone—Mental disorder—Carmustine—brain cancer	0.00386	0.0145	CcSEcCtD
Drospirenone—AR—Coregulation of Androgen receptor activity—CDK6—brain cancer	0.00385	0.0138	CbGpPWpGaD
Drospirenone—Nervous system disorder—Hydroxyurea—brain cancer	0.0038	0.0143	CcSEcCtD
Drospirenone—Skin disorder—Hydroxyurea—brain cancer	0.00376	0.0141	CcSEcCtD
Drospirenone—PTGS2—central nervous system—brain cancer	0.00376	0.00845	CbGeAlD
Drospirenone—Acute coronary syndrome—Etoposide—brain cancer	0.00374	0.014	CcSEcCtD
Drospirenone—Mental disorder—Temozolomide—brain cancer	0.00373	0.014	CcSEcCtD
Drospirenone—Myocardial infarction—Etoposide—brain cancer	0.00372	0.014	CcSEcCtD
Drospirenone—PTGS2—cerebellum—brain cancer	0.00367	0.00826	CbGeAlD
Drospirenone—PGR—Signaling by ERBB4—GFAP—brain cancer	0.00364	0.0131	CbGpPWpGaD
Drospirenone—AR—Notch-mediated HES/HEY network—HES1—brain cancer	0.00348	0.0125	CbGpPWpGaD
Drospirenone—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.00335	0.0126	CcSEcCtD
Drospirenone—AR—Regulation of Androgen receptor activity—SIRT1—brain cancer	0.00328	0.0118	CbGpPWpGaD
Drospirenone—PGR—Validated nuclear estrogen receptor alpha network—PCNA—brain cancer	0.00324	0.0117	CbGpPWpGaD
Drospirenone—Erythema multiforme—Etoposide—brain cancer	0.00322	0.0121	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.00314	0.0118	CcSEcCtD
Drospirenone—Angiopathy—Etoposide—brain cancer	0.00309	0.0116	CcSEcCtD
Drospirenone—Progesterone—CYP2C9—brain cancer	0.00302	0.272	CrCbGaD
Drospirenone—PTGS2—brain—brain cancer	0.00298	0.00671	CbGeAlD
Drospirenone—Nausea—Procarbazine—brain cancer	0.00297	0.0112	CcSEcCtD
Drospirenone—Nervous system disorder—Temozolomide—brain cancer	0.00297	0.0111	CcSEcCtD
Drospirenone—Skin disorder—Temozolomide—brain cancer	0.00294	0.011	CcSEcCtD
Drospirenone—Testosterone—CYP2C9—brain cancer	0.00286	0.257	CrCbGaD
Drospirenone—Gastrointestinal disorder—Carmustine—brain cancer	0.0027	0.0101	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Temozolomide—brain cancer	0.00261	0.0098	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.00251	0.00941	CcSEcCtD
Drospirenone—Skin disorder—Etoposide—brain cancer	0.00235	0.00883	CcSEcCtD
Drospirenone—Nausea—Hydroxyurea—brain cancer	0.0023	0.00863	CcSEcCtD
Drospirenone—AR—Androgen receptor signaling pathway—SIRT1—brain cancer	0.00217	0.0078	CbGpPWpGaD
Drospirenone—AR—Androgen receptor signaling pathway—CCNE1—brain cancer	0.00214	0.0077	CbGpPWpGaD
Drospirenone—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—brain cancer	0.00209	0.00753	CbGpPWpGaD
Drospirenone—Gastrointestinal disorder—Etoposide—brain cancer	0.00209	0.00785	CcSEcCtD
Drospirenone—PGR—Signaling by ERBB4—VAV1—brain cancer	0.00208	0.00748	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—GFAP—brain cancer	0.00195	0.00702	CbGpPWpGaD
Drospirenone—Nausea—Carmustine—brain cancer	0.00186	0.00698	CcSEcCtD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	0.00183	0.00657	CbGpPWpGaD
Drospirenone—PTGS2—S1P1 pathway—VEGFA—brain cancer	0.00183	0.00657	CbGpPWpGaD
Drospirenone—PGR—Validated nuclear estrogen receptor alpha network—CCND1—brain cancer	0.00181	0.00651	CbGpPWpGaD
Drospirenone—Nausea—Temozolomide—brain cancer	0.0018	0.00675	CcSEcCtD
Drospirenone—AR—Regulation of nuclear SMAD2/3 signaling—CDK4—brain cancer	0.00177	0.00636	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	0.00173	0.00623	CbGpPWpGaD
Drospirenone—AR—SIDS Susceptibility Pathways—ESR2—brain cancer	0.00172	0.00618	CbGpPWpGaD
Drospirenone—PTGS2—C-MYB transcription factor network—CDK6—brain cancer	0.00171	0.00616	CbGpPWpGaD
Drospirenone—PGR—Signaling by ERBB4—PDGFRA—brain cancer	0.0017	0.00612	CbGpPWpGaD
Drospirenone—AR—Coregulation of Androgen receptor activity—CDKN2A—brain cancer	0.0017	0.0061	CbGpPWpGaD
Drospirenone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—APC—brain cancer	0.00168	0.00605	CbGpPWpGaD
Drospirenone—NR3C2—Generic Transcription Pathway—ESR2—brain cancer	0.00156	0.00563	CbGpPWpGaD
Drospirenone—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—brain cancer	0.00153	0.00551	CbGpPWpGaD
Drospirenone—AR—Notch-mediated HES/HEY network—STAT3—brain cancer	0.00152	0.00548	CbGpPWpGaD
Drospirenone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CDK4—brain cancer	0.0015	0.00538	CbGpPWpGaD
Drospirenone—PGR—Signaling by ERBB4—IRS2—brain cancer	0.00149	0.00538	CbGpPWpGaD
Drospirenone—NR3C2—Generic Transcription Pathway—NOTCH2—brain cancer	0.00148	0.00533	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	0.00146	0.00526	CbGpPWpGaD
Drospirenone—PGR—Validated nuclear estrogen receptor alpha network—MYC—brain cancer	0.00145	0.00522	CbGpPWpGaD
Drospirenone—AR—Integrated Breast Cancer Pathway—BRCA2—brain cancer	0.00145	0.00521	CbGpPWpGaD
Drospirenone—Nausea—Etoposide—brain cancer	0.00144	0.0054	CcSEcCtD
Drospirenone—AR—Coregulation of Androgen receptor activity—CCND1—brain cancer	0.00143	0.00515	CbGpPWpGaD
Drospirenone—AR—Integrated Breast Cancer Pathway—SIRT1—brain cancer	0.00142	0.00511	CbGpPWpGaD
Drospirenone—AR—Coregulation of Androgen receptor activity—CTNNB1—brain cancer	0.00142	0.0051	CbGpPWpGaD
Drospirenone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—brain cancer	0.00136	0.00491	CbGpPWpGaD
Drospirenone—AR—SIDS Susceptibility Pathways—HES1—brain cancer	0.00133	0.0048	CbGpPWpGaD
Drospirenone—PTGS2—C-MYB transcription factor network—HES1—brain cancer	0.00126	0.00453	CbGpPWpGaD
Drospirenone—PTGS2—Selenium Micronutrient Network—SOD2—brain cancer	0.00121	0.00435	CbGpPWpGaD
Drospirenone—AR—Androgen receptor signaling pathway—RELA—brain cancer	0.00121	0.00434	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	0.0012	0.00432	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	0.00118	0.00423	CbGpPWpGaD
Drospirenone—PTGS2—Aryl Hydrocarbon Receptor—RELA—brain cancer	0.00118	0.00423	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	0.00116	0.00418	CbGpPWpGaD
Drospirenone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CCND1—brain cancer	0.00115	0.00415	CbGpPWpGaD
Drospirenone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CTNNB1—brain cancer	0.00114	0.00411	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—OR14C36—brain cancer	0.00112	0.00404	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—OR4C12—brain cancer	0.00112	0.00404	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.0011	0.00397	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	0.00108	0.00389	CbGpPWpGaD
Drospirenone—AR—Integrated Breast Cancer Pathway—CDK4—brain cancer	0.00107	0.00386	CbGpPWpGaD
Drospirenone—AR—Androgen receptor signaling pathway—CCND1—brain cancer	0.00106	0.00381	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	0.00105	0.00378	CbGpPWpGaD
Drospirenone—AR—Androgen receptor signaling pathway—CTNNB1—brain cancer	0.00105	0.00377	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	0.00103	0.0037	CbGpPWpGaD
Drospirenone—PGR—Signaling by ERBB4—ERBB2—brain cancer	0.00103	0.00369	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	0.000996	0.00358	CbGpPWpGaD
Drospirenone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—brain cancer	0.000991	0.00356	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—DTX2—brain cancer	0.000955	0.00343	CbGpPWpGaD
Drospirenone—PGR—Generic Transcription Pathway—ESR2—brain cancer	0.000953	0.00343	CbGpPWpGaD
Drospirenone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—brain cancer	0.000925	0.00333	CbGpPWpGaD
Drospirenone—AR—Regulation of nuclear SMAD2/3 signaling—MYC—brain cancer	0.000916	0.00329	CbGpPWpGaD
Drospirenone—AR—Androgen receptor signaling pathway—STAT3—brain cancer	0.000914	0.00329	CbGpPWpGaD
Drospirenone—BCHE—Peptide hormone metabolism—CTNNB1—brain cancer	0.000909	0.00327	CbGpPWpGaD
Drospirenone—BCHE—Phospholipid metabolism—PIK3CG—brain cancer	0.000908	0.00327	CbGpPWpGaD
Drospirenone—PGR—Generic Transcription Pathway—NOTCH2—brain cancer	0.000902	0.00325	CbGpPWpGaD
Drospirenone—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—brain cancer	0.0009	0.00324	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	0.00089	0.0032	CbGpPWpGaD
Drospirenone—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—brain cancer	0.000846	0.00304	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	0.00084	0.00302	CbGpPWpGaD
Drospirenone—NR3C2—Gene Expression—DNMT1—brain cancer	0.000839	0.00302	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—APC—brain cancer	0.000838	0.00301	CbGpPWpGaD
Drospirenone—AR—Androgen receptor signaling pathway—EGFR—brain cancer	0.000831	0.00299	CbGpPWpGaD
Drospirenone—PTGS2—Aryl Hydrocarbon Receptor—MYC—brain cancer	0.000828	0.00298	CbGpPWpGaD
Drospirenone—PTGS2—Aryl Hydrocarbon Receptor—EGFR—brain cancer	0.00081	0.00291	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—IDH1—brain cancer	0.000806	0.0029	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.000759	0.00273	CbGpPWpGaD
Drospirenone—PTGS2—C-MYB transcription factor network—CDKN2A—brain cancer	0.000755	0.00271	CbGpPWpGaD
Drospirenone—NR3C2—Gene Expression—ESR2—brain cancer	0.000753	0.00271	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—CDK4—brain cancer	0.000752	0.00271	CbGpPWpGaD
Drospirenone—AR—Generic Transcription Pathway—ESR2—brain cancer	0.000726	0.00261	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—PTCH2—brain cancer	0.000724	0.0026	CbGpPWpGaD
Drospirenone—NR3C2—Gene Expression—NOTCH2—brain cancer	0.000713	0.00257	CbGpPWpGaD
Drospirenone—PGR—Signaling by ERBB4—EGFR—brain cancer	0.000711	0.00256	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—HES5—brain cancer	0.000701	0.00252	CbGpPWpGaD
Drospirenone—PTGS2—Selenium Micronutrient Network—RELA—brain cancer	0.0007	0.00252	CbGpPWpGaD
Drospirenone—AR—Integrated Breast Cancer Pathway—CCND1—brain cancer	0.000694	0.0025	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	0.00069	0.00248	CbGpPWpGaD
Drospirenone—AR—Generic Transcription Pathway—NOTCH2—brain cancer	0.000688	0.00247	CbGpPWpGaD
Drospirenone—AR—Integrated Breast Cancer Pathway—CTNNB1—brain cancer	0.000687	0.00247	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—STRADA—brain cancer	0.00068	0.00245	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	0.000677	0.00243	CbGpPWpGaD
Drospirenone—AR—SIDS Susceptibility Pathways—CTNNB1—brain cancer	0.000669	0.00241	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	0.000668	0.0024	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	0.000651	0.00234	CbGpPWpGaD
Drospirenone—PTGS2—C-MYB transcription factor network—CCND1—brain cancer	0.000638	0.00229	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	0.000621	0.00223	CbGpPWpGaD
Drospirenone—NR3C2—Gene Expression—SIRT1—brain cancer	0.000607	0.00218	CbGpPWpGaD
Drospirenone—AR—Integrated Breast Cancer Pathway—VEGFA—brain cancer	0.000605	0.00218	CbGpPWpGaD
Drospirenone—PTGS2—Disease—DTX2—brain cancer	0.000597	0.00215	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	0.000592	0.00213	CbGpPWpGaD
Drospirenone—AR—SIDS Susceptibility Pathways—VEGFA—brain cancer	0.000589	0.00212	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	0.000575	0.00207	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	0.000569	0.00205	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—ABR—brain cancer	0.000568	0.00204	CbGpPWpGaD
Drospirenone—AR—Integrated Breast Cancer Pathway—MYC—brain cancer	0.000556	0.002	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—IDH1—brain cancer	0.000555	0.002	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—GLI2—brain cancer	0.000548	0.00197	CbGpPWpGaD
Drospirenone—AR—Integrated Breast Cancer Pathway—EGFR—brain cancer	0.000544	0.00196	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—GLI1—brain cancer	0.000516	0.00185	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	0.000512	0.00184	CbGpPWpGaD
Drospirenone—PTGS2—C-MYB transcription factor network—MYC—brain cancer	0.000511	0.00184	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—DNMT1—brain cancer	0.000511	0.00184	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	0.000501	0.0018	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—IL2—brain cancer	0.000498	0.00179	CbGpPWpGaD
Drospirenone—NR3C2—Generic Transcription Pathway—MYC—brain cancer	0.000494	0.00178	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—CYP2C9—brain cancer	0.000491	0.00177	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—SUFU—brain cancer	0.000489	0.00176	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—CCND1—brain cancer	0.000486	0.00175	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—APC—brain cancer	0.000482	0.00173	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—GFAP—brain cancer	0.000472	0.0017	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	0.000461	0.00166	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—ESR2—brain cancer	0.000459	0.00165	CbGpPWpGaD
Drospirenone—AR—Integrated Breast Cancer Pathway—TP53—brain cancer	0.000457	0.00164	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	0.000451	0.00162	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—HEY1—brain cancer	0.000447	0.00161	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—DLL1—brain cancer	0.000438	0.00158	CbGpPWpGaD
Drospirenone—PTGS2—Disease—HES5—brain cancer	0.000438	0.00158	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—NOTCH2—brain cancer	0.000435	0.00156	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—BSG—brain cancer	0.000417	0.0015	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—MYC—brain cancer	0.00039	0.0014	CbGpPWpGaD
Drospirenone—AR—Gene Expression—DNMT1—brain cancer	0.000389	0.0014	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—EGFR—brain cancer	0.000381	0.00137	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	0.000379	0.00136	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	0.000374	0.00135	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—SHH—brain cancer	0.000373	0.00134	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—SIRT1—brain cancer	0.000369	0.00133	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—TRPC6—brain cancer	0.000359	0.00129	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—IDH1—brain cancer	0.000359	0.00129	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—SMO—brain cancer	0.000353	0.00127	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—PTCH1—brain cancer	0.000353	0.00127	CbGpPWpGaD
Drospirenone—AR—Gene Expression—ESR2—brain cancer	0.00035	0.00126	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—CYP2C9—brain cancer	0.000338	0.00122	CbGpPWpGaD
Drospirenone—AR—Gene Expression—NOTCH2—brain cancer	0.000331	0.00119	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	0.00033	0.00119	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	0.000327	0.00118	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—TP53—brain cancer	0.00032	0.00115	CbGpPWpGaD
Drospirenone—PGR—Generic Transcription Pathway—MYC—brain cancer	0.000301	0.00108	CbGpPWpGaD
Drospirenone—PTGS2—Disease—IDH1—brain cancer	0.000295	0.00106	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	0.000292	0.00105	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	0.000288	0.00104	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—BSG—brain cancer	0.000287	0.00103	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—ENO2—brain cancer	0.000284	0.00102	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—NOTCH2—brain cancer	0.000283	0.00102	CbGpPWpGaD
Drospirenone—AR—Gene Expression—SIRT1—brain cancer	0.000281	0.00101	CbGpPWpGaD
Drospirenone—PTGS2—Disease—HEY1—brain cancer	0.00028	0.00101	CbGpPWpGaD
Drospirenone—PTGS2—Disease—DLL1—brain cancer	0.000274	0.000987	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—VAV1—brain cancer	0.000269	0.000969	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	0.000265	0.000954	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	0.000259	0.000933	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—IDH1—brain cancer	0.000247	0.000889	CbGpPWpGaD
Drospirenone—NR3C2—Gene Expression—MYC—brain cancer	0.000238	0.000855	CbGpPWpGaD
Drospirenone—PTGS2—Disease—SHH—brain cancer	0.000233	0.000839	CbGpPWpGaD
Drospirenone—PTGS2—Disease—ENO2—brain cancer	0.000233	0.000839	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—HES1—brain cancer	0.000232	0.000833	CbGpPWpGaD
Drospirenone—AR—Generic Transcription Pathway—MYC—brain cancer	0.000229	0.000824	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—PDGFRA—brain cancer	0.000221	0.000793	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	0.000218	0.000783	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—SPP1—brain cancer	0.000214	0.00077	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	0.000201	0.000724	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—ENO2—brain cancer	0.000195	0.000702	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—IRS2—brain cancer	0.000194	0.000697	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of proteins—CTNNB1—brain cancer	0.000172	0.000617	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—PIK3CG—brain cancer	0.000171	0.000615	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—APC—brain cancer	0.000171	0.000615	CbGpPWpGaD
Drospirenone—PTGS2—Disease—VAV1—brain cancer	0.000168	0.000606	CbGpPWpGaD
Drospirenone—PTGS2—Disease—HES1—brain cancer	0.000145	0.000521	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—MYC—brain cancer	0.000145	0.000521	CbGpPWpGaD
Drospirenone—PTGS2—Disease—PDGFRA—brain cancer	0.000138	0.000496	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—RELA—brain cancer	0.000134	0.000481	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—ERBB2—brain cancer	0.000133	0.000478	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—PIK3CG—brain cancer	0.00013	0.000468	CbGpPWpGaD
Drospirenone—PTGS2—Disease—IRS2—brain cancer	0.000121	0.000436	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—IL2—brain cancer	0.00012	0.000433	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CCND1—brain cancer	0.000117	0.000422	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CTNNB1—brain cancer	0.000116	0.000418	CbGpPWpGaD
Drospirenone—AR—Gene Expression—MYC—brain cancer	0.00011	0.000397	CbGpPWpGaD
Drospirenone—PTGS2—Disease—APC—brain cancer	0.000107	0.000385	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—VEGFA—brain cancer	0.000102	0.000368	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—STAT3—brain cancer	0.000101	0.000364	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—MYC—brain cancer	9.41e-05	0.000338	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—EGFR—brain cancer	9.2e-05	0.000331	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—PIK3CG—brain cancer	8.96e-05	0.000322	CbGpPWpGaD
Drospirenone—PTGS2—Disease—ERBB2—brain cancer	8.31e-05	0.000299	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—TP53—brain cancer	7.73e-05	0.000278	CbGpPWpGaD
Drospirenone—PTGS2—Disease—CTNNB1—brain cancer	7.27e-05	0.000261	CbGpPWpGaD
Drospirenone—PTGS2—Disease—STAT3—brain cancer	6.33e-05	0.000228	CbGpPWpGaD
Drospirenone—PTGS2—Disease—MYC—brain cancer	5.89e-05	0.000212	CbGpPWpGaD
Drospirenone—PTGS2—Disease—EGFR—brain cancer	5.76e-05	0.000207	CbGpPWpGaD
